Namwiwat Medical Corporation Valuation

Q: What is the Fair Price of NAM-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

NAM-R (THB4.5) is trading above our estimate of [[fair value]] (THB1.48)

Is NAM-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NAM-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NAM-R (THB4.5) is trading above our estimate of fair value (THB1.48)

Significantly Below Fair Value: NAM-R is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NAM-R?

Key metric: As NAM-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NAM-R. This is calculated by dividing NAM-R's market cap by their current earnings.
What is NAM-R's PE Ratio?
PE Ratio	18.1x
Earnings	฿174.33m
Market Cap	฿3.15b

NAM-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.5x
Enterprise Value/EBITDA	10.5x
PEG Ratio	1x

Price to Earnings Ratio vs Peers

How does NAM-R's PE Ratio compare to its peers?

The above table shows the PE ratio for NAM-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	23.8x
TOG Thai Optical Group	12.2x	n/a	฿4.7b
LPH Ladprao General Hospital	45.2x	n/a	฿3.1b
TRP Aesthetic Connect	20.7x	22.1%	฿3.1b
RPH Ratchaphruek Hospital	17.1x	n/a	฿3.0b
NAM-R Namwiwat Medical Corporation	18.1x	17.9%	฿3.2b

Price-To-Earnings vs Peers: NAM-R is good value based on its Price-To-Earnings Ratio (18.1x) compared to the peer average (23.8x).

Price to Earnings Ratio vs Industry

How does NAM-R's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: NAM-R is good value based on its Price-To-Earnings Ratio (18.1x) compared to the Asian Medical Equipment industry average (25.9x).

Price to Earnings Ratio vs Fair Ratio

What is NAM-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NAM-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	18.1x
Fair PE Ratio	22.4x

Price-To-Earnings vs Fair Ratio: NAM-R is good value based on its Price-To-Earnings Ratio (18.1x) compared to the estimated Fair Price-To-Earnings Ratio (22.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Nonthavej Hospital

฿5.0b

Operates as a hospital in Thailand.

NTV

฿31.25

-15.5%

Master Style

฿13.0b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿43.25

3.0%

-8.0%

Safe Fertility Group

฿3.7b

Provides fertility medical center services in Thailand.

SAFE-R

฿12.30

4.2%

-26.3%